The need for new therapies to treat systemic fungal infections continues to
rise. Naturally occurring hexapeptide echi-nocandin B (1) has shown potent
antifungal activity via its inhibition of the synthesis of beta-1,3 glucan
, a key fungal cell wall component. Although this series of agents has been
limited thus far based on their physicochemical characteristics, we have f
ound that the synthesis of analogues bearing an aminoproline residue in the
'northwest' position imparts greatly improved water solubility ( > 5 mg/mL
). The synthesis and structure-activity relationships (SAR) based on whole
cell and upon in vivo activity of the series of compounds are reported. (C)
2000 Elsevier Science Ltd. All rights reserved.